AKT1 and cancer: Abnormal activation of PI3K/AKT is known to cause multi-drug resistance by inhibiting apoptosis, promoting cell survival, and enhancing cancer stem cell characteristics, partially through its mediators such as ABC transporters, GSK-3β, and mTOR.